21 Jan 2022
Positive Top-Line Results for BIMZELX[®]▼(bimekizumab) in Second Phase 3 Psoriatic Arthritis Study
Read More
19 Jan 2022
18 Jan 2022
Positive Top-Line Results for BIMZELX[®]▼(bimekizumab) in Phase 3 Non-Radiographic Axial Spondyloarthritis Study
Read More
8 Jan 2022
3 Jan 2022
21 Dec 2021